Hester Biosciences Ltd confirmed the reappointment of Rajiv Gandhi as Chief Executive Officer and Managing Director. Gandhi, the company’s founder, continues to lead India’s leading animal healthcare firm, ensuring stability and strategic growth. The move reassures investors and strengthens confidence in Hester’s long-term vision.
Animal healthcare major Hester Biosciences Ltd has announced the reappointment of Rajiv Gandhi as CEO and Managing Director, reaffirming its commitment to leadership stability and strategic continuity. Gandhi, who founded the company in 1987, has been instrumental in transforming Hester into one of India’s largest animal healthcare firms, with a strong presence in vaccines, pharmaceuticals, and diagnostics.
Key Highlights
-
Leadership Continuity: Rajiv Gandhi’s reappointment ensures consistency in vision and execution, particularly as Hester expands its footprint in both domestic and international markets.
-
Strategic Growth: Under Gandhi’s leadership, Hester has diversified into poultry and large animal vaccines, positioning itself as a critical player in India’s livestock health sector.
-
Investor Confidence: The announcement comes at a time when the company is focusing on innovation and global partnerships, reassuring stakeholders about long-term stability.
-
Industry Impact: Gandhi’s continued role is expected to drive further R&D investments, strengthen supply chains, and enhance Hester’s contribution to India’s food security and animal health ecosystem.
The reappointment underscores Hester’s belief in Gandhi’s proven track record and his ability to steer the company through evolving industry challenges.
Sources: Reuters, Economic Times, Hester Biosciences Investor Relations